CING - Cingulate Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.54 -0.54 (-11.89%)	---	0.0 (0.07%)	0.02 (0.5%)	-0.35 (-7.71%)	-0.17 (-4.2%)	-0.01 (-0.25%)	-0.01 (-0.25%)

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.09
Diluted EPS:: -1.09
Basic P/E:: -3.6697
Diluted P/E:: -3.6697
RSI(14) 1m:: 50.0
VWAP:: 4.0
RVol:: 2.9537

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	4.68 -0.12 (-2.5%)	Oct 15 04:26
1m	Price decrease 1m	4.66 -0.16 (-3.32%)	Oct 15 04:24
10m	Price increase 10m	4.82 +0.22 (+4.78%)	Oct 15 04:23
60m	Price increase 60m	4.82 +0.28 (+6.17%)	Oct 15 04:23